arrow
B

Bert A. Bonsing

erasmus mc cancer institute
H指数:56
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of pathological diagnosis on postoperative outcomes after pancreatoduodenectomy: A nationwide cohort study

胰腺十二指肠切除术后病理诊断对预后的影响:一项全国性队列研究

EJSO
IF2.9
2026-07-010
OAAI
Surgical outcomes from nationwide implementation of the international best practice for locally advanced pancreatic cancer (PREOPANC-4) study

国际最佳实践在局部晚期胰腺癌中的全国性实施研究(PREOPANC-4)的手术结果

2026-06-220
OAAI
Continuity of care experienced by patients diagnosed with pancreatic cancer: nationwide multicentre study

胰腺癌患者体验到的护理连续性:全国多中心研究

2026-05-210
OA
Regional variation for tumour-directed treatment and survival in patients with pancreatic adenocarcinoma: a nationwide population-based analysis.

胰腺腺癌患者区域性治疗方案与生存率的地区差异:一项全国性基于人群的分析。

HPB
IF2.4
2025-12-300
PRE
Patient preferences for pancreatic cancer treatment (PERSEUS): a multicenter discrete choice experiment

患者对胰腺癌治疗偏好的研究(PERSEUS):一项多中心离散选择实验

2025-12-240
OAAI
Delayed gastric emptying after pancreatic cancer surgery impacts time to start of adjuvant treatment but not overall survival: a post-hoc analysis of the PREOPANC-1 and-2 trials

胰腺癌手术后胃排空延迟影响辅助治疗开始时间,但不影响总生存期:一项对PREOPANC-1和-2试验的事后分析

2025-12-010
PRE
Pancreatic cancer surveillance not recommended for familial adenomatous polyposis: a fine and gray risk analysis

胰腺癌筛查不推荐用于家族性腺瘤性息肉病:一项Fine和Gray风险分析

2025-11-250
PRE
ASO Visual Abstract: Impact of Different Primary Treatment Strategies on Recurrence-Focused Treatment of Pancreatic Ductal Adenocarcinoma

ASO视觉摘要:不同初始治疗策略对胰腺导管腺癌复发导向治疗的影响

2025-11-250
PRE
Impact of Different Primary Treatment Strategies on Recurrence-Focused Treatment of Pancreatic Ductal Adenocarcinoma

不同初级治疗策略对复发导向的胰腺导管腺癌治疗的影响

2025-11-070
PRE
Timing of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma: A Nationwide Analysis

胰腺导管腺癌患者辅助化疗时机的全国性分析

2025-11-050
OAAI
Oncological outcome after robot-assisted versus open pancreatoduodenectomy for upfront resectable cancer in the pancreatic head: a nationwide cohort analysis
2025-11-010
OA
Nationwide outcomes of 1000 robotic pancreatoduodenectomies across the four phases of the learning curve
2025-11-010
OA
Increased incidence, survival, and registration quality of primary hepato-pancreato-biliary cancers in the Netherlands Cancer Registry

荷兰癌症登记处原发性肝胰胆管癌的发病率、生存率和登记质量均有所提高。

2025-09-120
PREAI
Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial

新辅助FOLFIRINOX与基于吉西他滨的新辅助化放疗在可切除和边界可切除胰腺癌中的比较(PREOPANC-2):一项多中心、开放标签、III期随机试验

2025-09-100
PRE
Resectability stages of pancreatic cancer: nationwide reference

胰腺癌的可切除性分期:全国性参考

BJS
IF8.7
2025-07-030
OA
Impact of feeding strategy after pancreatoduodenectomy on delayed gastric emptying and hospital stay: nationwide study

胰腺十二指肠切除术后喂养策略对胃排空延迟和住院时间的影响:全国性研究

2025-06-010
PRE
Intraparenchymal Enzyme Injections in Islet Isolations With Incomplete Ductal Perfusion of Enzymes

在酶灌注不完全的胰岛分离中进行的实质内酶注射

2025-04-300
OA
Computer-Aided Decision Support and 3D Models in Pancreatic Cancer Surgery: A Pilot Study
2025-02-260
OAAI
Biliary drainage prior to pancreatoduodenectomy with endoscopic ultrasound-guided choledochoduodenostomy versus conventional ERCP: propensity score-matched study and surgeon survey

术前超声内镜引导下胆肠吻合术与常规ERCP在胰腺十二指肠切除术前的胆道引流:倾向性评分匹配研究及外科医生调查

ENDOSCOPY
IF12.8
2025-02-200
OA